2013 NCPA Awards Forms
2013 Independent Pharmacist of the Year
2013 Prescription Drug Safety Award
2012 Fungal Meningitis Outbreak
One-Sheet explanation of proposed Federal Legislation in response to outbreak.
CDC HAN 00333 Contamination identified in additional medical products from NECC.
Health Advisory from Kentucky Department of Health, 10/29/2012
For more information on this advisory, or to report cases, contact Dr. Terry Bunn email@example.com 859-257-4955
CDC & FDA release 10/4/2012
Kentucky Release 10/8/2012
FDA Alert 10/15/2012
FDA issued an updated MedWatch Safety alert on the ongoing meningitis outbreak associated with the injection of products distributed by New England Compounding Pharmacy (NECC). The alert includes a complete list of the medications recalled. In the FDA statement, two new suspect products are identified (triamcinolone acetonide and cardioplegic solution). FDA is also updating the recommendations for actions by health care professionals and patients. The FDA is especially interested in notifying members of FDA’s interest in receiving adverse event reports, through theFDA Medwatch online reporting system, if you suspect that the use of an NECC injectable product is associated with a serious infection.
Preliminary Report on Investigation